Captor Capital Corp.

Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. The company owns and operates a retail chain of nine dispensaries in California, including Santa Cruz, Antioch, El Sobrante, Salinas, Lompoc, Goleta, Atwater, Palm Springs, and Castroville under the One Plant brand name. It also operates an e-commerce site under One Plant brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2, 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.

Captor Capital Corp. trades as CPTR.CN on CNQ. The company is classified in Healthcare / Drug Manufacturers - Specialty & Generic and reports in CAD.

The current profile places the business in Drug Manufacturers - Specialty & Generic. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows -$1.74M of revenue and $7.70M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Captor Capital Corp. can be compared against peers such as CENTR Brands Corp., Entheon Biomedical Corp., Optimind Pharma Corp., Ovation Science Inc., Planet Based Foods Global Inc., RAMM Pharma Corp..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $767,125, beta of 1.05, and return on equity of +52.1%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CPTR.CN currently shows total debt of $0 and beta of 1.05. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://captorcapital.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.